The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Targeting DNA topoisomerase II in cancer chemotherapy
Open accessAbstract
Recent molecular studies have expanded the biological contexts in which topoisomerase II (TOP2) has crucial functions, including DNA replication, transcription and chromosome segregation. Although the biological functions of TOP2 are important for ensuring genomic integrity, the ability to interfere with TOP2 and generate enzyme-mediated DNA damage is an effective strategy for cancer chemotherapy. The molecular tools that have allowed an understanding of the biological functions of TOP2 are also being applied to understanding the details of drug action. These studies promise refined targeting of TOP2 as an effective anticancer strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Gewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240
DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS
Liu, L. F. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002031 · Cited by 1,811
Keeney, S., Giroux, C. N., & Kleckner, N. (1997) · Cell · doi:10.1016/s0092-8674(00)81876-0 · Cited by 1,809
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., & Liu, L. F. (1984) · Science · doi:10.1126/science.6093249 · Cited by 1,538
Human CtIP promotes DNA end resection
Sartori, A. A., Lukas, C., Coates, J., Mistrik, M., Fu, S., Bartek, J., Baer, R., Lukas, J., & Jackson, S. P. (2007) · Nature · doi:10.1038/nature06337 · Cited by 1,362
ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1
Zhao, H., & Piwnica-Worms, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4129-4139.2001 · Cited by 1,091
Tewey, K. M., Chen, G. L., Nelson, E. M., & Liu, L. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)47282-6 · Cited by 887
Structure and mechanism of DNA topoisomerase II
Berger, J. M., Gamblin, S. J., Harrison, S. C., & Wang, J. C. (1996) · Nature · doi:10.1038/379225a0 · Cited by 859
The mechanism of topoisomerase I poisoning by a camptothecin analog
Staker, B. L., Hjerrild, K., Feese, M. D., Behnke, C. A., Burgin, A. B., & Stewart, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242259599 · Cited by 818
Cao, L., Alani, E., & Kleckner, N. (1990) · Cell · doi:10.1016/0092-8674(90)90072-m · Cited by 675
Lyu, Y. L., Kerrigan, J. E., Lin, C.-P., Azarova, A. M., Tsai, Y.-C., Ban, Y., & Liu, L. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1649 · Cited by 612
Endonucleolytic processing of covalent protein-linked DNA double-strand breaks
Neale, M. J., Pan, J., & Keeney, S. (2005) · Nature · doi:10.1038/nature03872 · Cited by 609
Tebbi, C. K., London, W. B., Friedman, D., Villaluna, D., De Alarcon, P. A., Constine, L. S., Mendenhall, N. P., Sposto, R., Chauvenet, A., & Schwartz, C. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.3879 · Cited by 493
Chen, G. L., Yang, L., Rowe, T. C., Halligan, B. D., Tewey, K. M., & Liu, L. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90729-5 · Cited by 492
Late formation and prolonged differentiation of the Moon inferred from W isotopes in lunar metals
Touboul, M., Kleine, T., Bourdon, B., Palme, H., & Wieler, R. (2007) · Nature · doi:10.1038/nature06428 · Cited by 466
Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441
Zhao, Y., Thomas, H. D., Batey, M. A., Cowell, I. G., Richardson, C. J., Griffin, R. J., Calvert, A. H., Newell, D. R., Smith, G. C. M., & Curtin, N. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4275 · Cited by 445
Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
D’Arpa, P., Beardmore, C., & Liu, L. F. (1990) · PubMed · Cited by 425
Chen, L., Nievera, C. J., Lee, A. Y.-L., & Wu, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710245200 · Cited by 424
Secondary leukemias induced by topoisomerase-targeted drugs
Felix, C. A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00139-0 · Cited by 418
Yang, S. W., Burgin, A. B., Huizenga, B. N., Robertson, C. A., Yao, K. C., & Nash, H. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11534 · Cited by 412
Energy coupling in DNA gyrase and the mechanism of action of novobiocin
Sugino, A., Higgins, N. P., Brown, P. O., Peebles, C. L., & Cozzarelli, N. R. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.4838 · Cited by 403
Yeast Gene for a Tyr-DNA Phosphodiesterase that Repairs Topoisomerase I Complexes
Pouliot, J. J., Yao, K. C., Robertson, C. A., & Nash, H. A. (1999) · Science · doi:10.1126/science.286.5439.552 · Cited by 382
Topoisomerase II as a target for anticancer drugs: When enzymes stop being nice
Fortune, J. M., & Osheroff, N. (2000) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(00)64006-0 · Cited by 366
Holm, C., Covey, J. M., Kerrigan, D., & Pommier, Y. G. (1989) · PubMed · Cited by 366
Roca, J., Ishida, R., Berger, J. M., Andoh, T., & Wang, J. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1781 · Cited by 348
Limbo, O., Chahwan, C., Yamada, Y., de Bruin, R. A. M., Wittenberg, C., & Russell, P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.009 · Cited by 323
Roca, J., & Wang, J. C. (1992) · Cell · doi:10.1016/0092-8674(92)90558-t · Cited by 317
Fluoroquinolones: Action and Resistance
Drlica, K., & Malik, M. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452537 · Cited by 317
Structural basis for gate-DNA recognition and bending by type IIA topoisomerases
Dong, K. C., & Berger, J. M. (2007) · Nature · doi:10.1038/nature06396 · Cited by 316
Topoisomerase levels determine chemotherapy response in vitro and in vivo
Burgess, D. J., Doles, J., Zender, L., Xue, W., Ma, B., McCombie, W. R., Hannon, G. J., Lowe, S. W., & Hemann, M. T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803513105 · Cited by 300
Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.
Tanabe, K., Ikegami, Y., Ishida, R., & Andoh, T. (1991) · PubMed · Cited by 292
Repair of Topoisomerase I‐Mediated DNA Damage
Pommier, Y., Barcelo, J. M., Rao, V. A., Sordet, O., Jobson, A. G., Thibaut, L., Miao, Z., Seiler, J. A., Zhang, H., Marchand, C., et al. (2006) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(06)81005-6 · Cited by 291
Self-citationSae2 Is an Endonuclease that Processes Hairpin DNA Cooperatively with the Mre11/Rad50/Xrs2 Complex
Lengsfeld, B. M., Rattray, A. J., Bhaskara, V., Ghirlando, R., & Paull, T. T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.001 · Cited by 290
Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies
Azarova, A. M., Lyu, Y. L., Lin, C.-P., Tsai, Y.-C., Lau, J. Y.-N., Wang, J. C., & Liu, L. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704002104 · Cited by 286
DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia
Mistry, A. R., Felix, C. A., Whitmarsh, R. J., Mason, A., Reiter, A., Cassinat, B., Parry, A., Walz, C., Wiemels, J. L., Segal, M. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042715 · Cited by 281
Cell death induced by topoisomerase-targeted drugs: more questions than answers
Kaufmann, S. H. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00136-5 · Cited by 278
Willmore, E., de Caux, S., Sunter, N. J., Tilby, M. J., Jackson, G. H., Austin, C. A., & Durkacz, B. W. (2004) · Blood · doi:10.1182/blood-2003-07-2527 · Cited by 273
Classen, S., Olland, S., & Berger, J. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832879100 · Cited by 263
Catalytic inhibitors of DNA topoisomerase II
Andoh, T., & Ishida, R. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00133-x · Cited by 231
Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage
Vance, J. R., & Wilson, T. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202242599 · Cited by 217
Prinz, S., Amon, A., & Klein, F. (1997) · Genetics · doi:10.1093/genetics/146.3.781 · Cited by 212
Keeney, S., & Kleckner, N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11274 · Cited by 211
Avemann, K., Knippers, R., Koller, T., & Sogo, J. M. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3026 · Cited by 211
Hartsuiker, E., Neale, M. J., & Carr, A. M. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.11.021 · Cited by 210
SCAN1 mutant Tdp1 accumulates the enzyme–DNA intermediate and causes camptothecin hypersensitivity
Interthal, H., Chen, H. J., Kehl‐Fie, T. E., Zotzmann, J., Leppard, J. B., & Champoux, J. J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600694 · Cited by 199
26 S Proteasome-mediated Degradation of Topoisomerase II Cleavable Complexes
Mao, Y., Desai, S. D., Ting, C.-Y., Hwang, J., & Liu, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104009200 · Cited by 196
Ishida, R., Miki, T., Narita, T., Yui, R., Sato, M., Utsumi, K. R., Tanabe, K., & Andoh, T. (1991) · PubMed · Cited by 192
Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
Järvinen, T. A. H., Tanner, M., Barlund, M. T., Borg, Å., & Isola, J. J. (1999) · PubMed · Cited by 188
Capranico, G., Kohn, K. W., & Pommier, Y. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.22.6611 · Cited by 186
Pedersen-Bjergaard, J., Philip, P., Larsen, S. O., Andersson, M. V., Daugaard, G., Ersbøll, J., Sw, H., HOU-JENSEN, K., Nielsen, D. L., & Sigsgaard, T. (1993) · PubMed · Cited by 181
Stanulla, M., Wang, J., Chervinsky, D. S., Thandla, S., & Aplan, P. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4070 · Cited by 178
Antitopoisomerase drug action and resistance
Nitiss, J. L., & Beck, W. T. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00056-1 · Cited by 177
Self-citationHardcastle, I. R., Cockcroft, X., Curtin, N. J., El-Murr, M. D., Leahy, J. J. J., Stockley, M., Golding, B. T., Rigoreau, L., Richardson, C., Smith, G. C. M., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050444b · Cited by 171
Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193
Adachi, N., Suzuki, H., Iiizumi, S., & Koyama, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306500200 · Cited by 169
Anthracycline-Induced Cardiotoxicity
Ferreira, A., Matsubara, L., & Matsubara, B. (2008) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152508785909474 · Cited by 168
The Crystal Structure of Human Tyrosyl-DNA Phosphodiesterase, Tdp1
Davies, D. R., Interthal, H., Champoux, J. J., & Hol, W. G. J. (2002) · Structure · doi:10.1016/s0969-2126(02)00707-4 · Cited by 168
Marchand, C., Antony, S., Kohn, K. W., Cushman, M., Ioanoviciu, A., Staker, B. L., Burgin, A. B., Stewart, L., & Pommier, Y. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0456 · Cited by 167
Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery
Pommier, Y., & Cherfils, J. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.008 · Cited by 165
Cardiotoxicity of Antitumor Drugs
Menna, P., Salvatorelli, E., & Minotti, G. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800002r · Cited by 163
Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage
Nitiss, K. C., Malik, M., He, X., White, S. W., & Nitiss, J. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603455103 · Cited by 159
Self-citationRatain, M. J., & Rowley, J. D. (1992) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058121 · Cited by 156
Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae
Pouliot, J. J., Robertson, C. A., & Nash, H. A. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00452.x · Cited by 152
A Protease Pathway for the Repair of Topoisomerase II-DNA Covalent Complexes
Zhang, A., Lyu, Y. L., Lin, C., Zhou, N., Azarova, A. M., Wood, L. M., & Liu, L. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604149200 · Cited by 146
Robinson, M. J., Martin, B. A., Gootz, T. D., McGuirk, P. R., Moynihan, M. S., Sutcliffe, J. A., & Osheroff, N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98726-0 · Cited by 145
A Two-drug Model for Etoposide Action against Human Topoisomerase IIα
Bromberg, K. D., Burgin, A. B., & Osheroff, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212056200 · Cited by 145
DNA Topoisomerase II as a Target for Cancer Chemotherapy
Walker, J. V., & Nitiss, J. L. (2002) · Cancer Investigation · doi:10.1081/cnv-120002156 · Cited by 139
Self-citationMechanisms of Camptothecin Resistance by Human Topoisomerase I Mutations
Chrencik, J., Staker, B. L., Burgin, A. B., Pourquier, P., Pommier, Y. G., Stewart, L. J., & Redinbo, M. R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.03.077 · Cited by 136
Gudkov, A. V., Zelnick, C. R., Kazarov, A. R., Thimmapaya, R., Suttle, D. P., Beck, W. T., & Roninson, I. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3231 · Cited by 136
Plx1 is required for chromosomal DNA replication under stressful conditions
Trenz, K., Errico, A., & Costanzo, V. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.29 · Cited by 129
Pommier, Y. G., Schwartz, R. E., Zwelling, L. A., & Kohn, K. W. (1985) · Biochemistry · doi:10.1021/bi00344a014 · Cited by 128
Zechiedrich, L., Christiansen, K., Andersen, A. H., Westergaard, O., & Osheroff, N. (1989) · Biochemistry · doi:10.1021/bi00441a014 · Cited by 126
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma
Palumbo, A., Gay, F., Bringhen, S., Falcone, A. P., Pescosta, N., Callea, V., Caravita, T., Morabito, F., Magarotto, V., Ruggeri, M., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn018 · Cited by 123
Deng, C., Brown, J. M., Dongqing, Y., & Brown, J. M. (2005) · Genetics · doi:10.1534/genetics.104.028795 · Cited by 119
Barry, E. V., Vrooman, L. M., Dahlberg, S. E., Neuberg, D. S., Asselin, B. L., Athale, U. H., Clavell, L. A., Larsen, E. C., Moghrabi, A., Samson, Y., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2481 · Cited by 118
DNA sequence selectivity of topoisomerases and topoisomerase poisons
Capranico, G., & Binaschi, M. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00135-3 · Cited by 116
Treszezamsky, A. D., Kachnic, L. A., Feng, Z., Zhang, J., Tokadjian, C., & Powell, S. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0601 · Cited by 113
Topoisomerase IIα controls the decatenation checkpoint
Luo, K., Yuan, J., Chen, J., & Lou, Z. (2008) · Nature Cell Biology · doi:10.1038/ncb1828 · Cited by 112
G2 arrest in response to topoisomerase II inhibitors: the role of p53.
Clifford, B., Beljin, M., Stark, G. R., & Taylor, W. R. (2003) · PubMed · Cited by 109
Inhibition of DNA Decatenation, but Not DNA Damage, Arrests Cells at Metaphase
Skoufias, D. A., Lacroix, F., Andreassen, P. R., Wilson, L., & Margolis, R. L. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.018 · Cited by 104
NK314, a Topoisomerase II Inhibitor That Specifically Targets the α Isoform
Toyoda, E., Kagaya, S., Cowell, I. G., Kurosawa, A., Kamoshita, K., Nishikawa, K., Iiizumi, S., Koyama, H., Austin, C. A., & Adachi, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803936200 · Cited by 102
Nucleolytic processing of a protein-bound DNA end by the E. coli SbcCD (MR) complex
Connelly, J. C., de Leau, E. S., & Leach, D. R. F. (2003) · DNA repair · doi:10.1016/s1568-7864(03)00063-6 · Cited by 101
Cardiotoxic Consequences of Anthracycline-Containing Therapy in Patients With Breast Cancer
Jensen, B. V. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.022 · Cited by 92
An Essential Role for MCL-1 in ATR-mediated CHK1 Phosphorylation
Jamil, S., Mojtabavi, S., Hojabrpour, P., Cheah, S., & Duronio, V. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-11-1171 · Cited by 89
A Yeast Type II Topoisomerase Selected for Resistance to Quinolones
Elsea, S. H., Hsiung, Y. G., Nitiss, J. L., & Osheroff, N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.4.1913 · Cited by 87
Self-citationTopoisomerase II Poisoning by ICRF-193
Huang, K.-C., Gao, H., Yamasaki, E. F., Grabowski, D., Liu, S., Shen, L. L., Chan, K. K., Ganapathi, R. N., & Snapka, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104383200 · Cited by 82
Repair of DNA Covalently Linked to Protein
Connelly, J. C., & Leach, D. R. F. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00056-5 · Cited by 82
Biard, D. S. F. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm195 · Cited by 80
Mano, M. S., Rosa, D. D., de Azambuja, E., Ismael, G., & Durbecq, V. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.10.001 · Cited by 76
Darroudi, F., Wiegant, W. W., Meijers, M., Friedl, A. A., van der Burg, M., Fomina, J. N., van Dongen, J. J. M., van Gent, D. C., & Zdzienicka, M. Z. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.11.029 · Cited by 69
Long-term XPC Silencing Reduces DNA Double-Strand Break Repair
Despras, E., Pfeiffer, P., Salles, B., Calsou, P., Kuhfittig-Kulle, S., Angulo, J. F., & Biard, D. S. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3371 · Cited by 63
Ayene, I. S., Ford, L. P., & Koch, C. J. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0130 · Cited by 63
Wang, L., & Eastmond, D. A. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10072 · Cited by 62
Roles of nonhomologous end-joining pathways in surviving topoisomerase II–mediated DNA damage
Malik, M., Nitiss, K. C., Enriquez-Rios, V. D., & Nitiss, J. L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0263 · Cited by 62
Self-citationCellular processing pathways contribute to the activation of etoposide-induced DNA damage responses
Fan, J.-R., Peng, A., Chen, H.-C., Lo, S.-C., Huang, T. H., & Li, T. (2008) · DNA repair · doi:10.1016/j.dnarep.2007.12.002 · Cited by 61
Bandele, O. J., & Osheroff, N. (2008) · Biochemistry · doi:10.1021/bi800981j · Cited by 60
Adachi, N., Iiizumi, S., So, S., & Koyama, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.099 · Cited by 59
Jin, S. (1998) · Carcinogenesis · doi:10.1093/carcin/19.6.965 · Cited by 57
DNA Repair Functions That Control Sensitivity to Topoisomerase-Targeting Drugs
Malik, M., & Nitiss, J. L. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.1.82-90.2004 · Cited by 53
Self-citationHoughton, J. A., Cheshire, P. J., Hallman, J. D., Lutz, L., Luo, X., Li, Y., & Houghton, P. J. (1996) · PubMed · Cited by 50
Therapeutic Exploitation of Tumor Cell Defects in Homologous Recombination
Powell, S. N., & Kachnic, L. A. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008784220267 · Cited by 49
Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites
Fedier, A., Schlamminger, M., Schwarz, V. A., Haller, U., Howell, S. B., & Fink, D. A. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg240 · Cited by 48
The role of TDP1 from budding yeast in the repair of DNA damage
Liu, C., Pouliot, J. J., & Nash, H. A. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.030 · Cited by 45
The Requirement of Artemis in Double-Strand Break Repair Depends on the Type of DNA Damage
Kurosawa, A., Koyama, H., Takayama, S.-I. J., Miki, K., Ayusawa, D., Fujii, M., Iiizumi, S., & Adachi, N. (2007) · DNA and Cell Biology · doi:10.1089/dna.2007.0649 · Cited by 44
He, X., van Waardenburg, R. C. A. M., Babaoglu, K., Price, A. C., Nitiss, K. C., Nitiss, J. L., Bjornsti, M., & White, S. W. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.07.055 · Cited by 43
Self-citationEtoposide-related acute promyelocytic leukemia
Kudo, K., Yoshida, H., Kiyoi, H., Numata, S., Horibe, K., & Naoe, T. (1998) · Leukemia · doi:10.1038/sj.leu.2401089 · Cited by 43
Rossi, R., Lidonnici, M. R., Soza, S., Biamonti, G., & Montecucco, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2741 · Cited by 42
Grüger, T., Nitiss, J. L., Maxwell, A., Zechiedrich, L., Heisig, P., Seeber, S., Pommier, Y. G., & Strumberg, D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4495-4504.2004 · Cited by 38
Self-citationHuang, R.-Y., Kowalski, D., Minderman, H., Gandhi, N. S., & Johnson, E. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2839 · Cited by 37
Topoisomerase II–DNA complexes trapped by ICRF‐193 perturb chromatin structure
Germe, T. R., & Hyrien, O. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400465 · Cited by 34
Mms22p protects Saccharomyces cerevisiae from DNA damage induced by topoisomerase II
Baldwin, E. L., Berger, A. C., Corbett, A. H., & Osheroff, N. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki246 · Cited by 33
Using Yeast to Understand Drugs that Target Topoisomerasesa
Nitiss, J. L., Rose, A., Sykes, K. C., HARRIS, J., & Zhou, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb26374.x · Cited by 33
Self-citationXiao, H., & Goodrich, D. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208958 · Cited by 30
Type II DNA Topoisomerase from Saccharomyces cerevisiae Is a Stable Dimer
Tennyson, R. B., & Lindsley, J. E. (1997) · Biochemistry · doi:10.1021/bi970152f · Cited by 30
Navid, F., Santana, V. M., Billups, C. A., Merchant, T. E., Furman, W. L., Spunt, S. L., Cain, A. M., Rao, B. N., Hale, G. A., & Pappo, A. S. (2006) · Cancer · doi:10.1002/cncr.21810 · Cited by 29
Huff, A. C., Ward, R. E., & Kreuzer, K. N. (1990) · Molecular and General Genetics MGG · doi:10.1007/bf00280363 · Cited by 29
Théard, D., Coisy‐Quivy, M., Ducommun, B., CONCANNON, P. J., & Darbon, J.-M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6095 · Cited by 28
Small Molecule Modulation of the Human Chromatid Decatenation Checkpoint
Haggarty, S. J., Koeller, K. M., Kau, T. R., Silver, P. A., Roberge, M., & Schreiber, S. L. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.11.014 · Cited by 25
Aratani, Y., Andoh, T., & Koyama, H. (1996) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(95)00049-6 · Cited by 23
Yeast as a Tool in Cancer Research
Nitiss, J. L., & Heitman, J. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5963-6 · Cited by 23
Self-citationIsolation and Characterization of mAMSA-hypersensitive Mutants
Rogojina, A. T., & Nitiss, J. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804058200 · Cited by 21
Self-citationCoutts, J., Plumb, J., Brown, R. E., & Keith, W. N. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.430 · Cited by 20
Choi, H. J., Cho, B. C., Shin, S. J., Cheon, S. H., Jung, J. Y., Chang, J., Kim, S. I., Sohn, J., & Kim, J. H. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0505-9 · Cited by 16
Robison, J. G., Bissler, J. J., & Dixon, K. (2007) · Cell Cycle · doi:10.4161/cc.6.19.4773 · Cited by 13
Donà (1992) · International Journal of Oncology · doi:10.3892/ijo_00000047 · Cited by 13
Lieu, C. H., Chow, L. Q. M., Pierson, A. S., Eckhardt, S., O’Bryant, C. L., Morrow, M., Tran, Z. V., Wright, J. J., & Gore, L. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9154-z · Cited by 11
Rogojina, A. T., Li, Z., Nitiss, K. C., & Nitiss, J. L. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5963-6_16 · Cited by 3
Self-citation
Cited by
Taxonomy, Physiology, and Natural Products of Actinobacteria
Barka, E. A., Vatsa, P., Sanchez, L., Gaveau-Vaillant, N., Jacquard, C., Klenk, H.-P., Clément, C., Ouhdouch, Y., & van Wezel, G. P. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00019-15 · Cited by 2,188
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Pommier, Y., Leo, E., Zhang, H., & Marchand, C. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.012 · Cited by 1,829
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
Roles of eukaryotic topoisomerases in transcription, replication and genomic stability
Pommier, Y., Sun, Y., Huang, S.-Y. N., & Nitiss, J. L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.111 · Cited by 950
Self-citationExploiting senescence for the treatment of cancer
Wang, L., Lankhorst, L., & Bernards, R. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00450-9 · Cited by 867
Metadata
- Authors
- Nitiss, J. L.
- Venue
- Nature Reviews Cancer
- Published
- 2009-04-20
- Volume
- 9
- Issue
- 5
- Pages
- 338-350
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2041051519
- Cited by
- 1,791
- References
- 128
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.